Fresenius Medical Care specialises in dialysis and the treatment of kidney (renal) disease & failure, Haemodialysis and Peritoneal Dialysis. Learn more about how we define the highest patient care standards.

About 3.5 million patients with this disease worldwide regularly undergo dialysis treatment. Fresenius Medical Care has served over 190,000 patients in over 2,400 US locations. We carry out over 575,000 dialysis treatments a year for almost 4,000 patients, in … abril 29, 2019. septiembre 2, 2019. Fresenius Medical Care is the world's largest integrated provider of products and services for individuals undergoing dialysis.
At the end of 2019, our patent portfolio comprised some 10,658 property rights in approximately 1,518 patent families, i.e.

We are the leading independent provider of renal services working in partnership with the NHS. Fresenius Medical Care is the world’s leading provider of dialysis products and services. Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure. We care for people with chronic kidney failure, of whom around 3.5 million worldwide depend on dialysis treatment. groups of patents linked to the same invention. As a vertically integrated company, we provide a complete solution for people with chronic kidney failure – from research and development to manufacturing our dialysis products to providing complete therapy options within our own clinics. Mas informacíon. Fresenius Medical Care México. Fresenius Medical Care has been caring for NHS kidney patients in the UK for over 20 years. Mas Información In fiscal year 2019, Fresenius Medical Care spent a total of around €168 M on research and development (2018: €114 M), corresponding to around 5 % (2018: 3 %) of our health care product revenue. Fresenius Medical Care supplies extra dialysis machines for COVID-19 patients in U.S. Fresenius Medical Care North America is making 150 additional dialysis machines available to U.S. hospitals for the emergency treatment of COVID-19 patients, under the company’s newly established National Intensive Renal Care Reserve.